Иммуногистохимическая характеристика карциноидов легочной локализации
Диссертация
Особое значение имеет изучение экспрессии ряда клеточных маркеров, участвующих в механизмах канцерогенеза, таких как протеины, связанные с апоптозом, межклеточной адгезией и пролиферацией. Молекулы адгезии экспрессируются в нормальном бронхиальном эпителии, а при нейроэндокринной мелкоклеточной карциноме наблюдается слабая экспрессия, либо ее отсутствие (Nitadori J. et al., 2005). В некоторых… Читать ещё >
Список литературы
- Бабиченко И.Н., Ковязин В. А. Новые методы иммуногистохимической диагностики опухолевого роста. -М.: РУДН, 2008. 109с.
- Бирюков Ю.В. Хирургия бронхолёгочных карциноидов (40-летний опыт) // Анналы хирургии. 2005. — № 6. — С.30−34.
- Гаганов JI.E., Гуревич Л. Е., Корсакова H.A. с соавт. Особенности экспрессии Е-кадхерина в карциномах желудка // Альманах клинической медицины. 2011.-№ 25. — С.3−8.
- Гордеева A.B., Лабас Ю. А., Звягильская P.A. с соавт. Апоптоз одноклеточных организмов: механизмы и эволюция // Биохимия. -2004.-№ 69.-С. 1301—1313.
- Дерижанова И.С. Опухоли диффузной эндокринной системы карциноиды. Ростов-на-Дону, 1991.-285 с.
- Дерижанова И.С., Резникова Г. Л. Электронно-макроскопическая характеристика карциноидных опухолей различной локализации.//Архив патологии. 1986. -№ 1. — С.56−62.
- Жукова Л.Г. Современные возможности и перспективы таргетной терапии при раке молочной железы // Практическая онкология. 2010.-т.11. -№ 3. C.182%191.
- Забелина В.Д. Карциноидные опухоли редкая болезнь или редкий диагноз? // Справочник поликлинического врача. 2010. — N 12.-С.16−21.
- Зеленов Г. Г., Туманова Е.JI. Колокольчикова Е. Г. с соавт. Морфологические критерии злокачественности парасимпатических параганглиом (хемодектом) // Вестник Российского государственного медицинского университета. 2011.- № 5. — С.42−44.
- Имянитов E.H. Эпидемиология и биология нейроэндокринных опухолей // Практическая онкология. 2005. — Т. 6, N 4. — С.202−205.
- Кабанов С.Н., Карташов С. З., Непомнящая Е. М. с соавт. Современный взгляд на проблему нейроэндокринных опухолей лёгких // Известия высших учебных заведений. 2011. — № 3. — С. 92−95.
- Карташов С.З., Кабанов С. Н., Непомнящая Е. М. с соавт. Бронхолёгочные карциноиды // Известия высших учебных заведений. 2006. -№S15. — С. 15−19.
- Коган Е.А., Коваленко Н. А., Маркова A.C. С соавт. Молекулярные маркеры в диагностике и прогнозировании рака предстательной железы (иммуногистохимическое исследование) // Вопросы биологической и фармацевтической химии. 2010. -№ 3. — С.13−18.
- Лазебник Л.Б., Демченко А. М., Ильченко Л. Ю. с соавт. Карциноидная опухоль бронха с метастазами в лёгкие и орбиту // Экспериментальная и клиническая гастроэнтерология. 2003. — № 5. — С.112−114.
- Лушников Е.Ф., Абросимов А. Ю. Гибель клетки (апоптоз). М.: Медицина, 2001.-192с.
- Маслякова Г. Н., Понукалин А. Н., Цмокалюк E.H. с соавт. Роль иммуногистохимических маркеров в диагностике рака мочевого пузыря // Саратовский научно-медицинский журнал. 2009. — Т.5, № 4. -С.608−611.
- Парамонова Н.Б. Морфологическая и молекулярно-биологическая характеристика дисрегенераторных изменений эпителия лёгкого человека: Автореф. дис. канд.мед.наук / М., Московская медицинская академия им. Сеченова, 2003.
- Петров С. В. Райхлин Н.Т. Руководство по иммуногистохимической диагностике опухолей человека 3-е изд, дополненное и переработанное. Казань: Изд-во «Титул», 2004. -451с.
- Пикин О.В., Колбанов К. И., Рудаков Р. В. с соавт. Изолированная резекция правого главного бронха с формированием полибронхиального анастомоза при типичном центральном карциноиде // Российский онкологический журнал. 2011. — № 4. — С. 46−48.
- Пинский С.Б., Дворниченко В. В., Репета O.P. с соавт. Множественная эндокринная неоплазия 1-го типа // Сибирский медицинский журнал. -2009.-Т. 87, № 4.-С. 9−16.
- Райхлин Н.Т., Смирнова Е. А., Полоцкий Б. Е. с соавт. Электронно-микроскопическое исследование карциноидов лёгкого // Арх.патологии. 1999. Т. 61. № 5. — С. 69−79.
- Рыбакова М.Г., Трофимов В. И., Минеев В. Н. с соавт. Оценка активности генов-регуляторов апоптоза по экспрессии Bel-2, Вах, активности каспазы-3 в бронхиальных эпителиальных клетках у больных бронхиальной астмой // Архив патологии, 2011. — № 1. -С.11−14.
- Рябцева С. Н., Рогов Ю. И., Смолякова P.M. с соавт. Сравнительная морфологическая характеристика гастроинтестинальных стромальных опухолей и гладкомышечных новообразований // Онкологический журнал. 2010. — Т.4, № 2. — С. 50−56.
- Стенина М.Б., Фролова М. А. Рак молочной железы: наиболее важные научные события и выводы последних лет. Практическая онкология. 2011- 12(1): 6−11.
- Суходоло И.В., Мильто И. В., Геренг Е. А. с соавт. Дисперсная эндокринная система и концепция APUD // Морфология. 2011. — Т. 137, № 2.-С. 80−89.
- Трахтенберг А.Х., Колбанов К. И., Франк Г. А., с соавт. Особенности диагностики и лечения карциноидных опухолей лёгких // Пульмонология и аллергология. 2009. — № 1. — С. 2−6.
- Трахтенберг А.Х., Франк Г. А., Пикин О. В. с соавт. Нейроэндокринные опухоли лёгких- опыт диагностики и лечения // Российский онкологический журнал. 2011. — № 4. — С.8−14.
- Тюльпаков А.Н., Рожинская Л. Я., Мокрышева Н.Г с соавт. Особенности диагностики и лечения пациентов с синдромом множественных эндокринных неоплазий 1 -го типа // Consilium medicum. 2010. — № 12.-С.87−93.
- Чекини А. К. Павловская А.И. Морфологические особенности карциноидных опухолей лёгкого и тимуса // Архив патологии. 2012. -№ 2.-С. 40−41.
- Чумаков П.М. Белок р53 и его универсальные функции в многоклеточном организме // Успехи биологической химии. 2007. -Т. 47. — С. 3−52.
- Afify A., McNiel М.А., Braggin J. et al. Expression of CD44s, CD44v6, and hyaluronan across the spectrum of normal-hyperplasia-carcinoma inbreast // Appl Immunohistochem Mol Morpho. -2008. Vol. l6№ 2. -P. 121−7.
- Afify A.M., Tate S., Durbin-Johnson B. et al. Expression of CD44s and CD44v6 in lung cancer and their correlation with prognostic factors // Int J Biol Markers. 2011. — Vol.26, № 1. — P.50−7.
- Aimola P., Carmignani M., Volpe A.R. et al. Cadmium Induces p53-Dependent Apoptosis in Human Prostate Epithelial Cells // PLoS One. -2012. -Vol.7, № 3.-P 36−43.
- Akintola-Ogunremi O., Pfeifer J.D., Tan B.R. et al. Analysis of protein expression and gene mutation of c-kit in colorectal neuroendocrine carcinomas // Am J Surg Pathol. 2003. — Vol.27, № 12. — P. 1551−8.
- Alaniz L., Cabrera P.V., Blanco G. et al. Interaction of CD44 with different forms of hyaluronic acid. Its role in adhesion and migration of tumor cells // Cell Commun Adhes.- 2002. Vol. 9, № 3. -P. 117−30.
- Alpini G., Invernizzi P., Gaudio E. et al. Serotonin metabolism is dysregulated in cholangiocarcinoma, which has implications for tumor growth. // Cancer Res. -2008. Vol.68, № 22. -P. 9184−93.
- Amirghofran Z., Monabati A., Khezri A. et al. Apoptosis in transitional cell carcinoma of bladder and its relation to proliferation and expression of p53 and bcl-2 // Pathol Oncol Res. 2004. — Vol.10, № 3. — P. 154−8.
- Annenkov A., Nishikura K., Domori K. et al. Alpha-methylacyl-coenzyme A racemase expression in neuroendocrine neoplasms of the stomach // Virchows Arch. 2012. — Vol.461, № 2. — P. 169−175.
- Aplin A.E., Howe A., Alahari S.K. et al. Signal transduction and signal modulation by cell adhesion receptors: the role of integrins, cadherins, immunoglobulin-cell adhesion molecules, and selectins // Pharmacol Rev-1998-№ 50 .-P. 197−263.
- Arbiser Z.K., Arbiser J.L., Cohen C. et al. Neuroendocrine lung tumors: grade correlates with proliferation but not angiogenesis // Mod Pathol. -2001. Vol.14, № 12. -P.l 195−9.
- Arshad H., Ahmad Z., Hasan S.H. et al. Gliomas: correlation of histologic grade, Ki67 and p53 expression with patient survival // Asian Pac J Cancer Prev.- 2010.1- Vol 1, № 6.-P. 1637−40.
- August C., August K., Schroeder S. et al. CGH and CD 44/MIB-l immunohistochemistry are helpful to distinguish metastasized from nonmetastasized sporadic pheochromocytomas // Mod Pathol. -2004. Vol. 17, № 9.-P.l 119−28.
- Aydin E., Yazici U., Gulgosteren M. et al. Long-term outcomes and prognostic factors of patients with surgically treated pulmonary carcinoid: our institutional experience with 104 patients // Eur J Cardiothorac Surg. -2011. Vol.39,№ 4.-P.549−54.
- Bajwa N., Liao C., Nikolovska-Coleska Z. et al. Inhibitors of the anti-apoptotic Bcl-2 proteins: a patent review // Expert Opin Ther Pat. 2012-Vol.22, №l.-P.37−55.
- Baldi A., De Luca A., Esposito V. et al. Tumor suppressors and cell-cycle proteins in lung cancer publishing online. // Patholog Res Int. 2011. URL: http://www.hindawi.com/journals/pri/2011/605 042/
- Baldi A., Groger A.M., Esposito V. et al. Neuroendocrine differentiation in non-small cell lung carcinomas // In Vivo. 2000. — Vol.14, № 1. — P. 10 914.
- Beasley M.B., Lantuejoul S., Abbondanzo S. et al. The pl6/cyclin Dl/Rb pathway in neuroendocrinetumors of the lung // Hum Pathol. 2003. -№ 34. -P.136−142.
- Beasley M.B., Thunnissen F.B., Brambilla E. et al. Pulmonary atypical carcinoid: predictors of survival in 106 cases // Hum Pathol. 2000. -Vol.31, № 10.-P.1255−65.
- Bensch K.G., Gordon G.B., Miller L.R. et al. Studies on thebronchial counterpart of the Kultschitzky (argentaffifi n) cell and innervation of bronchial glands // J Ultrastruct Res. 1965. -№ 12. — P.668−686.
- Berretta M., Cappellani A., Di Vita M. et al. Biomarkers in neuroendocrine tumors. // Front Biosci (Schol Ed). 2010. — № 2. — P. 332−42.
- Bishr Omary M., Piene M.D. et al. Intermediate Filament Proteins and Their Associated Diseases // The new england journal medicine. 2004. — № 351. -P.2087−2100.
- Bosman F., Carneiro F., Hruban R. et al. WHO Classification of Tumours of the Digestive System. Lyon: IARC Press- 2010. — 417p.
- Brambilla C., Fievet F., Jeanmart M. et al. Early detection of lung cancer: role of biomarkers // Eur Respir J Suppl. 2003. — № 39. — P.36−44.
- Brambilla E., Negoescu A., Gazzeri S. et al. Apoptosis-related factors p53, Bcl2, and Bax in neuroendocrine lung tumors // Am J Pathol 1996 — Vol. 149, № 6. — P.1941−52.
- Brezicka T. Expression of epithelial-cell adhesion molecule (Ep-CAM) in small cell lung cancer as defined by monoclonal antibodies 17−1A and BerEP4 // Acta Oncol. 2005. — Vol.44, № 7. — P.723−7
- Bubb R.S., Komaki R., Hachiya T. et al. Association of Ki-67, p53, and bcl-2 expression of the primary non-small-cell lung cancer lesion with brain metastatic lesion // Int J Radiat Oncol Biol Phys. 2002. — Vol. 53, № 5. -P.1216−24.
- Buchwalow I.B. Immunohistochemistry: Basics and Methods. Springer: Berlin.- 2010. 153p.
- Byrd-Gloster A.L., Khoor A., Glass L.F. et al. Differential expression of thyroid transcription factor 1 in small cell lung carcinoma and Merkel cell tumor // Hum Pathol. 2000. — Vol. 31, № 1. — P.58−62.
- Cagle P. T., Allen T. Advances in Surgical Pathology: Lung Cancer. -Philadelphia: Lippincott Williams & Wilkins, 2010. 303p.
- Cai Y.C., Banner B., Glickman J. et al. Cytokeratin 7 and 20 and thyroid transcription factor 1 can help distinguish pulmonary from gastrointestinal carcinoid and pancreatic endocrine tumors // Hum Pathol. 2001. — Vol.32, № 10.-P. 1087−93.
- Camilo R., Capelozzi V.L., Siqueira S.A. et al. Expression of p63, keratin 5/6, keratin 7, and surfactant-A in non-small cell lung carcinomas // Hum Pathol. 2006. — Vol.37, № 5. — P.542−6.
- Chan E.S., Alexander J., Swanson P.E. et al. PDX-1, CDX-2, TTF-1, and CK7: a reliable immunohistochemical panel for pancreatic neuroendocrine neoplasms.//.Am J Surg Pathol. 2012. — Vol.36, № 5. -P.737−43.
- Chang J.H., Kim S.W., Chung W. C. et al. Clinical review of gastrointestinal carcinoid tumor and analysis of the factors predicting metastasis // Korean J Gastroenterol. 2007. — Vol.50, № 1. — P.19−25.
- Chang M.H., Lee K., Lee K.Y. et al. Prognostic role of integrin pi, E-cadherin, and racl expression in small cell lung cancer // APMIS. 2012. -Vol. 120, № 1. -P.28−38.
- Chang Y.L., Lee Y. C., Liao W.Y. et al. The utility and limitation of thyroid transcription factor-1 protein in primary and metastatic pulmonary neoplasm // Lung Cancer.- 2004. Vol.44, № 2. — P. 149−57.
- Chen J. Clinicopathologic study of paraganglioma // Zhonghua Bing Li Xue Za Zhi. 2006. — Vol.35,№ 8, — P.494−6.
- Chen Y., Cui T., Yang L. et al. The diagnostic value of cytokeratin 5/6, 14, 17, and 18 expression in human non-small cell lung cancer // Oncology. -2011. Vol.80, № 5. — P.333−40.
- Chipuk J. E, Green D.R. How do BCL-2 proteins induce mitochondrial outer membrane permeabilization? // Trends Cell Biol. 2008. -Vol. 18,№ 4.- P. 157−64.
- Cho C.S., Labow D.M., Tang L. et al. Histologic grade is correlated with outcome after resection of hepatic neuroendocrine neoplasms // Cancer. -2008.-№ 113.-P.126−134.
- Chu P., Weiss L., Modern Immunohistochemistry. Cambridge: Cambridge University Press, 2009. — 712p.
- Clavel C.E., Nollet F., Berx G. et al. Expression of the E-cadherin-catenin complex in lung neuroendocrine tumours // J Pathol. 2001. — Vol. 194, № 1. -P.20−6.
- Dabbs D.J. Diagnostic immunohistochemistry. Churchill: Livingstone, 2002.-828p.
- Dardick I., Christensen H., Stratis M. et al. Immunoelectron microscopy for chromogranin A in small cell neuroendocrine carcinoma of lung // Ultrastruct Pathol. 1996. — Vol.20, № 4. — P.361−8.
- Das-Neves-Pereira J.C., Bagan P., Milanez-de-Campos J. et al. Individual risk prediction of nodal and distant metastasis for patients with typicalbronchial carcinoid tumors. R. Eur J Cardiothorac Surg.- 2008. Vol.34, № 3. -P.473−7.
- Davini F., Gonfiotti A., Comin C.J. et al. Typical and atypical carcinoid tumours: 20-year experience with 89 patients // Cardiovasc Surg. 2009. -Vol. 50, № 6.-P.807−11.
- Deftos L.J. Chromogranin A: its role in endocrine function and as an endocrine and neuroendocrine tumor marker // Endocr Rev. 1991. — Vol. 12, № 2.-P. 181−7.
- Demirci I., Herold S., Kopp A. et al. Overdiagnosis of a typical carcinoid tumor as an adenocarcinoma of the lung: a case report and review of the literature. // World J Surg Oncol. 2012. — Vol. l0,№l:19. -P.77−81.
- Diaz L.K., Zhou X., Wright E. T. et al. CD44 expression is associated with increased survival in node-negative invasive breast carcinoma // Clin Cancer Res. 2005. — Vol.11, № 9. — P.3309−14.
- Dominguez N., Estevez-Herrera J., Pardo M. R. et al. The Functional Role of Chromogranins in Exocytosis // J Mol Neurosci. 2012. — Vol.48, № 2. -P.317−22.
- Du E.Z., Goldstraw P., Zacharias J. et al. TTF-1 expression is specific for lung primary in typical and atypical carcinoids: TTF-1-positive carcinoids are predominantly in peripheral location // Hum Pathol. 2004. — Vol. 35, № 7. — P.825−31.
- Emanuel R.L., Torday J.S., Mu Q. et al. Bombesin-like peptides and receptors in normal fetal baboon lung: roles in lung growth and maturation //Am J Physiol. 1999. -№ 277. — P. 1003−17.
- Erickson L. A, Lloyd R.V. et al. Practical markers used in the diagnosis of endocrine tumors // Adv Anat Pathol. 2004. — Vol. 11, № 4, — P. 175−89.
- Erler B.S., Presby M.M., Finch M. et al. CD117, Ki-67, and p53 predict survival in neuroendocrine carcinomas, but not within the subgroup of small cell lung carcinoma // Tumour Biol. 2011. — Vol.32, № 1. — P. 107−11.
- Estaquier J., Vallette F., Vayssiere J. L. et al. The mitochondrial pathways of apoptosis // Adv Exp Med Biol. 2012. — № 942. — P. 157−83.
- Fahy B.N., Tang L.H., Klimstra D. et al. Carcinoid of the rectum risk stratification (CaRRS): a strategy for preoperative outcome assessment // Ann Surg Oncol. 2007. — № 14. — P.396−404.
- Fang Y.J., Zhang L., Wu X.J. et al. Impact of ER (3 and CD44 expression on the prognosis of patients with stage II colon cancer // Tumour Biol. 2012 .
- Farhat C. A., Parra E. R., Rogers A.V. et al. J Using electron microscopy and multivariate cluster analysis to determine diagnosis and prognosis in cases of neuroendocrine lung carcinoma // Bras Pneumol. 2008. — Vol.34, № 10. -P.804−11.
- Fasanella S., Leonardi E., Cantaloni C. et al. Proliferative activity in human breast cancer: Ki-67 automated evaluation and the influence of different Ki-67 equivalent antibodies // Diagn Pathol. 2011. — Vol.30, № 6. — P.219−225
- Fassan M., Rea F. Somatostatin Treceptor type 2 (SSTR2) in bronchopulmonary carcinoids // Endocr Pathol. 2010. — Vol.21, № 3. -P.204−5.
- Ferrone C.R., Tang L. H., Tomlinson J. et al. Determining prognosis in patients with pancreatic endocrine neoplasms: can the WHO classification system be simplified? // J Clin Oncol. 2007. -№ 25. — P.5609−5615.
- Feyrter F. Jber diffuse endokrine epitheliale Organe. Leipzig: JA. Barth, 1938.
- Feyrter F. Zur Pathologie des argyrophilen Helle- Zell-Organes im Bronchialbaum des Menschen // VirchowsArch. 1954 — № 325. — P.723−732.
- Finkelstein S.D., Hasegawa T., Colby T. et al. Ilql3allelic imbalance discriminates pulmonary carcinoidsfrom tumorlets. A microdissection-based genotyping approach useful in clinical practice // Am J Pathol. -1999.-№ 155.-P.633−640.
- Fischer J. R., Lahm H. Validation of molecular and immunological factors with predictive importance in lung cancer.// Lung Cancer. 2004. -№ 45.-P. 151−61
- Frolich F. Die «Helle Zelle» der Bronchialschleimhaut und ihre Beziehungenzum Problem der Chemoreceptoren // Frankfurter Z Pathol. -1949. № 60.-P.517−559.
- Gall A., Sheppard M., John D L et al. p53, cellular proliferation, and apoptosis-related factors in thymic neuroendocrine tumors // Modern Pathology. 2004. — № 17. — P.33−39.
- Garcia-Yuste M., Molins L., Matilla J. M. et al. Estudio Multicentrico Espanol de los Tumores Neuroendocrinos del Pulmon de la Sociedad Espanola de Neumologia y Cirurgia Toracica. // Arch Bronconeumol. -2007. Vol. 43, № 10. — P.549−56.
- Gilani S.M., Tashjian R., Qu H. et al. Clear cell papillary renal cell carcinoma with characteristic morphology and immunohistochemical staining pattern // Pathologica. 2012. — Vol.104, № 3. — P. 101−4.
- Giotakis I., Chrysovergis A., Georgolios A. et al. Adhesion molecules in cancer of the head and neck: role of dysadherin // J BUON. 2011. -Vol.16, № 4.-P.609−12.
- Gmelich J.T., Bensch K.G., Liebow A. A. et al. Cells of Kultschitzky type in bronchioles and their relation to the origin of peripheral carcinoid tumor//Lab Invest-1967.-Vol. 17. № 1.-P.88−98.
- Goel A., Addis B. J. Pigmented atypical carcinoid of the lung // Histopathology. 2007. — Vol.51, № 2. — P.263−5.
- Gorshtein A., Gross D. J., Barak D. et al. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia and the associated lung neuroendocrine tumors: clinical experience with a rare entity // Cancer. 2012. -Vol.118,№ 3.-P.612−9.
- Gosney J.R., Sissons M. C., Allibone R. et al. Pulmonary endocrine cells in chronic bronchitis and emphysema // J Pathol. 1989. — Vol. 157,№ 2. -P.127−33.
- Gosset A., Masson P. Tumeurs endocrines de l’appendice // Presse Med. 1914. — № 25. — P.237−240.
- Gould Rothberg B.E., Bracken M.B. E-cadherin immunohistochemical expression as a prognostic factor in infiltrating ductal carcinoma of the breast: a systematic review and meta-analysis // Breast Cancer Res Treat. -2006.-№ 100.-P.139−148.
- Gould V.E., Linnoila R.I., Memoli V.A. et al. Neuroendocrine components of the bronchopulmonary tract: hyperplasias, dysplasias, and neoplasms //Lab Invest. 1983. — Vol.49, № 5. -P.519−37.
- Graadt van Roggen J.F., van Velthuysen M.L., Hogendoorn P. et al. The histopathological differential diagnosis of gastrointestinal stromal tumours // J Clin Pathol. 2001. — Vol.54, № 2. — P.96−102.
- Granberg D., Oberg K. Neuroendocrine tumours // Cancer Chemother Biol Response Modif. 2005. — № 22. — P.471−83.
- Granberg D., Skogseid B., Welin S. et al. Gastrin-releasing-peptide in neuroendorine tumours // Acta Oncol. 2006. — Vol.45, № 1. — P.23−7.
- Granberg D., Wilander E, Oberg K. et al. Expression of tyrosine kinase receptors in lung carcinoids // Tumour Biol. 2006. — Vol.27, № 3. — P. 1537.
- Granberg D., Wilander E., Oberg K. et al. Prognostic markers in patients with typical bronchial carcinoid tumors // J Clin Endocrinol Metab. 2000. — Vol.85, №(9):3425−30.
- Gross D. J., Munter G., Bitan M. et al. The role of imatinib mesylate (Glivec) for treatment of patients with malignant endocrine tumors positive for c-kit or PDGF-R // Endocr Relat Cancer. 2006. — Vol.13, № 2. — P. 535−40.
- Gunia S., May M., Scholmann K. et al. Expression of alpha-methylacyl-CoA racemase correlates with histopathologic grading in noninvasive bladder cancer //Virchows Arch. 2008. — Vol.453, № 2. — P.165−70.
- Gustafsson B.I., Kidd M., Chan A. et al. Bronchopulmonary neuroendocrine tumors // Cancer. 2008. — Vol.113, № 1. -P.5−21.
- Ha S.Y., Lee J J., Cho J. et al. Lung parenchymal invasion in pulmonary carcinoid tumor: an important histologic feature suggesting the diagnosis of atypical carcinoid and poor prognosis. // Lung Cancer- 2013. Vol.80, № 2.-P. 146−52.
- Haley K.J., Drazen J.M., Osathanondh R. et al. Comparison of the ontogeny of protein gene product 9.5, chromogranin A and proliferating cell nuclear antigen in developing human lung // Microsc Res Tech. 1997. -Vol.37, №l.-P.62−8.
- Halfdanarson T.R., Rubin J., Farnell M. B. et al. Pancreatic endocrine neoplasms: epidemiology and prognosis ofpancreatic endocrine tumors // Endocr Relat Cancer. 2008. — Vol. 15, № 2. — P.409−27.
- Hamad A.M., Rizzardi G., Marulli G.J. et al. Nodal recurrence of pulmonary carcinoid 30 years after primary resection // Thorac Oncol. -2008-Vol.3, № 6.-P.680−1.
- Hamada S., Masago K., Mio T. et al. Good clinical response to imatinib mesylate in atypical thymic carcinoid With KIT overexpression // J Clin Oncol.-2011 Vol. 29№ 1. -P.9−10.
- Hamperl H. Uber gutartige Bronchialtumoren // Virchows Arch. 1937.
- Han H., Landreneau R.J., Santucci T.S. et al. Prognostic value of immunohistochemical expressions of p53, HER-2/neu, and bcl-2 in stage I non-small-cell lung cancer // Human Pathol. 2002. — № 3. — P.105−110.
- Heidenhain R Untersuchungen under den bau der labdrusen // Arch Mikr Anat. 1870. -№ 6.
- Hirohashi S., Kanai Y. Inactivation of the E-cadherin-mediated cell adhesion system in human cancers // Am J Pathol 1998. — № 153. — P.333−339.
- Hochwald S.N., Zee S., Conlon K. C. et al. Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups // J Clin Oncol. 2002. -№ 20. -P.2633−2642.
- Igaz P. MEN1 clinical background. // Adv Exp Med Biol. 2009. -№ 668.-P. 1−15.
- Ionescu D.N., Treaba D., Gilks C.B. et al. Nonsmall cell lung carcinoma with neuroendocrine differentiation-an entity of no clinical or prognostic significance // Am J Surg Pathol. 2007. -№ 31.- P26−32.
- Jamali M., Chetty R. Predicting prognosis in gastroentero-pancreatic neuroendocrine tumors: an overview and the value of ki-67 immunostaining //Endocr Pathol. -2008. -№ 19. -P.282−288.
- Jeanmart M., Lantuejoul S., Fievet F. et al. Value of immunohistochemical markers in preinvasive bronchial lesions in risk assessment of lung cancer // Clin Cancer Res. 2003. — Vol.9,№ 6. -P.2195−203.
- Jerome Marson V., Mazieres J. Expression of TTF-1 and cytokeratins in primary and secondary epithelial lung tumours: correlation with histological type and grade // Histopathology. 2004. — Vol.45, № 2a. — P. 125−34.
- Jiang Z, Fanger G. R., Woda B. A. et al. Expression of alphamethyl acyl-Co A racemase (P504s) in various malignant neoplasms and normal tissues: a study of 761 cases // Hum Pathol. 2003. — № 34. -P.792−796.
- Jirasek T., Hozak P., Mandys V. et al. Different patterns of chromogranin A and Leu-7 (CD57) expression in gastrointestinal carcinoids: immunohistochemical and confocal laser scanning microscopy study // Neoplasma. 2003. — Vol.50, № 1. — P. 1−7.
- Johnen G., Krismann M., Jaworska M. et al. CGH findings in neuroendocrine tumours of the lung. // Pathologe. 2003. — Vol.24, № 4. -P. 303−7.
- Johnson D.E., Loch J.E., Elde R.P. et al. Pulmonary neuroendocrine cells in bronchopulmonary dysplasia and hyaline membrane disease // Pediatr Res 1982. № 16. — P.446154.
- Johnson D.E., Wobken J.D., Landrum B. G. et al. Changes in bombesin, calcitonin and serotonin immunoreactive pulmonary neuroendocrine cells in cystic fifibrosis and after prolonged mechanical ventilation // Am Rev RespirDis.- 1988.-№ 137.-P. 123−131.
- Johnson R., Trocha S., McLawhorn M. et al. Histology, not lymph node involvement, predicts long-term survival in bronchopulmonary carcinoids // Am Surg. 2011. — Vol.77, № 12. — P. 1669−74.
- Kajstura J., Rota M., Hall S. R. et al. Evidence for human lung stem cells //NewEngl. J. Med. -2011. Vol.364, № 19. -P.1795−806.
- Kaltsas G. A, Besser G. M., Grossman A. B. et al. The diagnosis and medical management of advanced neuroendocrine tumors.// Endocr Rev. -2004. Vol. 25, № 3. -P.458−511.
- Karray-Chouayekh S., Trifa F., Khabir A. et al. Negative/Low HER2 expression alone or combined with E-cadherin positivity is predictive of better prognosis in patients with breast carcinoma // Histol Histopathol. -2012. Vol.27, № 3. -P.377−85.
- Kato Y., Hirano T., Yoshida K. et al. Frequent loss of E-cadherin and/or catenins in intrabronchial lesions during carcinogenesis of the bronchial epithelium // Lung Cancer. 2005. — Vol.48, № 3. — P.323−30.
- Kawahara M., Kammori M., Kanauchi H. et al. Immunohistochemical prognostic indicators of gastrointestinal carcinoid tumours // Eur J Surg Oncol. 2002. — Vol.28, № 2. — P. 140−6.
- Kende A.I., Carr, N.J., Sobin, L.H. et al. Expression of cytokeratins 7 and 20 in carcinomas of the gastrointestinal tract // Histopathology. -2003.-№ 42.-P. 137−40.
- Kerr J.F., Wyllie A.H., Currie A.R. et al. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissuekinetics // Br J Cancer 1972. Vol.26, № 4. -P.239−257.
- Kevin O., Leslie M.D. Practical Pulmonary Pathology: Diagnostic Approach. Charlottesville: Elsevier Health Sciences, 2011- 828p.
- Klimstra D., David S., Irvin R. et al. The Pathologic Classification of Neuroendocrine Tumors: A Review of Nomenclature, Grading, and Staging Systems // Pancreas. 2010. — Vol. 39, № 6. — P. 707−712.
- Ko Y.H., Won H.S., Jeon E.K. et al. Prognostic significance of CD44s expression in resected non-small cell lung cancer // BMC Cancer. 2011. -№ 11. -P.340−7.
- Kobayashi Y, Tokuchi Y, Hashimoto T, et al. Molecular markers for reinforcement of histological subclassification of neuroendocrine lung tumors. // Cancer Sei. 2004. — № 95. — P.334−41.
- Kontogianni K., Nicholson A. G., Butcher D. et al. CD56: a useful tool for the diagnosis of small cell lung carcinomas on biopsies with extensive crush artefact // J Clin Pathol. 2005. — Vol. 58, № 9. — P.978−80.
- Korner M.U., Hayes G.M., Carrigan P.E. et al. Wild-type and splice-variant secretin receptors in lung cancer: overexpression in carcinoid tumors and peritumoral lung tissue. // Mod Pathol. 2008. -Vol 21, № 4- P.387−95.
- Kourda N., Mlika M., Derouiche A. et al. The utility of alpha-methyl CoA racemase (P504S) expression as a marker of renal cell carcinomas. // Tunis Med. 2010. — Vol.88, № 8. — P.651−4.
- Kramer R. Adenoma of bronchus. // Ann Otol Rhinol Laryngol. 1930. -№ 39.-P. 689.
- Kuhnen C., Winter B.U. EGFR-expression in pulmonary neuroendocrine cell hyperplasia//Pathologe. 2006. — Vol.27, № 2. — P. 147−51.
- Kulchitsky N. Zur Frage uber den Bau des Darmkanals. // Arch Mikr Anat. 1897. — № 49.
- Kwon S.E., Chapman E. R. Synaptophysin regulates the kinetics of synaptic vesicle endocytosis in central neurons // Neuron. 2011. — Vol. 70, № 5. -P.847−54.
- Laennec R. Traite de 1'Auscultation Mediate et des Maladues des Poumons et du Coeur. Chaude: Paris. — 1931. — 672p.
- Langfort R., Rudzinski P., Burakowska B. et al. Pulmonary neuroendocrine tumors. The spectrum of histologic subtypes and current concept on diagnosis and treatment // Pneumonol Alergol Pol. 2010. -Vol.78, №l.-P.33−46.
- Langley K. The neuroendocrine concept today // Ann N Y Acad Sei. -1994. -№ 15. -P.l-17.
- Langner C., Rupar G., Leibi S. et al. Alpha-methylacyl-CoA racemase (AMACR/P504S) protein expression in urothelial carcinoma of the upper urinary tract correlates with tumour progression. // Virchows Arch. 2006. — Vol.448, № 3.-P.325−30.
- Lantuejoul S., Laverriere M. H., Sturm N. et al. NCAM (neural cell adhesion molecules) expression in malignant mesotheliomas. // Human Pathology. 2000. — Vol.31, № 4. — P.415−21.
- LaPoint R.J., Bourne P.A., Wang H.L. et al. Coexpression of c-kit and bcl-2 in small cell carcinoma and large cell neuroendocrine carcinoma of the lung. // Appl Immunohistochem Mol Morphol. 2007. — Vol.15, № 4. -P.401−6.
- Larsson C., Skogseid B., Oberg K. et al. Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. // Nordenskjold M.Nature. 1988. — № 3. — P.85−7.
- Lau S.K., Desrochers M.J., Luthringer D.J. et al. Expression of thyroid transcription factor-1, cytokeratin 7, and cytokeratin 20 in bronchioloalveolar carcinomas: an immunohistochemical evaluation of 67 cases. // Mod Pathol. 2002. — № 15. — P.538−42.
- Lauweryns J.M., Cokelaere M., Theunynck P.K. et al. Neuroepithelialbodies in the respiratory mucosa of various mammals: a light optical, histochemical, and ultrastructural investigation. //Z Zellforsch Mikrosk Anat. 1972. — № 135. — P.569−592.
- Leong A S.-Y., Cooper K. Leong F.J. et al. Manual of diagnostic antibodies for immunohistology, Second edition. Greenwich Medical Media: London. 2003. — 496p.
- Leroy X., Buisine M. P., Leteurtre E. et al. MUC1 (EMA):A key molecule of carcinogenesis? // Ann Pathol. 2006. — Vol.26. № 4. — P.257−66.
- Li A.F., Tsay S.H., Liang W.Y. et al. Clinical significance of pl6INK4a and p53 overexpression in endocrine tumors of the gastrointestinal tract // J Clin Pathol. 2006. — Vol. 126, № 6. P. — 856−65.
- Liao H., Rao H., Zhang X. et al. Retrospective study of clinicopathological characteristics in bronchopulmonary carcinoid // Zhongguo Fei Ai Za Zhi. 2010. — Vol.13, № 6. — P.591−7.
- Lin F., Prichard J. Handbook of Practical Immunohistochemistry. New York: Springer, 2011. — 619p.
- Lin X., Saad R.S., Luckasevic T.M. et al. Diagnostic value of CDX-2 and TTF-1 expressions in separating metastatic neuroendocrine neoplasms of unknown origin // Appl Immunohistochem Mol Morphol. 2007. -Vol.15,№ 4. -P.407−14.
- Liu A.Y., Vencio R.Z., Page L.S. et al. Bladder expression of CD cell surface antigens and cell-type-specific transcriptomes // Cell Tissue Res. -2012. Vol.348, № 3. — P.589−600.
- Liu E., Telem D.A., Warner R.R. et al. The role of Ki-67 in predicting biological behavior of goblet cell carcinoid tumor in appendix // Am J Surg. 2011. — Vol. 202, № 4. — P.400−3.
- Liu H.G., Kong M.X., Yao Q. et al. Expression of SoxlO and c-kit in Sinonasal Mucosal Melanomas Arising in the Chinese Population // Head Neck Pathol. 2012. — № 4. — P.401−8.
- Liu Y., Han S.S., Wu Y. et al. CD44 expression identifies astrocyte-restricted precursor cells // Dev Biol. 2004. — Vol.276, № 1. — P.31−46.
- Lloyd M.D., Darley D.J., Wierzbicki A.S. et al. Alpha-methylacyl-CoA racemase an 'obscure' metabolic enzyme takes centre stage // FEBS J. -2008. -№ 275. — P. 1089−1102.
- Lloyd R.V. Adrenal cortical tumors, pheochromocytomas and paragangliomas // Mod Pathol. 2011. -№ 24. — P.58−65.
- Lopez-Martin A., Ballestin C., Garcia-Carbonero R. et al. Prognostic value of KIT expression in small cell lung cancer // Lung Cancer. 2007. -Vol. 56, № 3. -P.405−13.
- Lu H. Y., Zhang G., Cheng Q.Y. et al. Expression and mutation of the c-kit gene and correlation with prognosis of small cell lung cancer // Oncol Lett. 2012. — Vol.4, № 1. — P.89−93.
- Lubarsch O. Ueber den primaren Krebs des Ileum, nebst Bemerkungen ber das gleichzeitige Vorkommen von Krebs und Tuberkolose // Virchows Arch. 1888. -№ 111. -P. 280−317
- Lubet R.A., Zhang Z., Wiseman R.W. et al. Use of p53 transgenic mice in the development of cancer models for multiple purposes, lung carcinomas // Exp Lung Res. 2000. — Vol. 26, № 8. — P.581−93.
- Luckraz H., Amer K., Thomas L. et al. Long-term outcome of bronchoscopically resected endobronchial typical carcinoid tumors // Journal of Thoracic and Cardiovascular Surgery. 2006. — Vol.132, № 1. -P.113−115.
- Macdonald D. C., Leir S. H., Brooks C. et al. CD44 isoform expression on colonic epithelium mediates lamina propria lymphocyte adhesion and is controlled by Thl and Th2 cytokines // Eur J Gastroenterol Hepatol. 2003. -Vol. 15, № 10. -P.1101−10.
- Machuca T.N., Cardoso P.F., Camargo S.M. et al. Surgical treatment of bronchial carcinoid tumors: a single-center experience // Lung Cancer. -2010. Vol.70, № 2. — P. 158−62.
- Martin B., Verdebout J.-M., Mascaux C. et al. Expression of p53 in preneoplastic and early neoplastic bronchial lesions // Oncol Rep. 2002. -№ 9. -P.223−229.
- Massoni Neto L.M., Bianchi C.P., Ab’Saber A.M. et al. p53 immunostaining is correlated with reduced survival and is not correlated with gene mutations in resected pulmonary large cell carcinomas // Med Biol Res. 2007 — Vol. 40, № 8. — P. 1045−53.
- Matsumura Y., Ishii G., Aokage K. et al. Morphophenotypical characteristics of intralymphatic cancer and stromal cell susceptible to lymphogenic metastasis // Cancer Sci. 2012. — Vol.103, № 7. — P. 1342−7.
- McDonald J.W., Pilgram T.K. Nuclear expression of p53, p21 and cyclin D1 is increased in bronchioloalveolar carcinoma // Histopathology. 1999. — № 34. — P.439−446.
- McKenney J.K., Desai S., Cohen C. et al. Discriminatory immunohistochemical staining of urothelial carcinoma in situ and nonneoplastic urothelium: an analysis of cytokeratin 20, p53, and CD44 antigens // Am J Surg Pathol. 2001. — № 25. — P. 1074−1078.
- Meda B. A., Frost M. BCL-2 is consistently expressed in hyperplastic marginal zones of the spleen, abdominal lymph nodes, and ileal lymphoid tissue // Am J Surg Pathol. 2003. — Vol. 27, № 7. — P.888−94.
- Mege R. M., Gavard J., Lambert M. et al. Regulation of cell-cell junctions by the cytoskeleton // Curr Opin Cell Biol. 2006. — Vol. 18, № 5. -P.541−8.
- Meister P. Histological grading of soft tissue sarcomas: stratification of G2-sarcomas in low- or high-grade malignant tumors // Pathologe. 2005. -Vol. 26, № 2.-P. 146−8.
- Mikhailov V., Mikhailova M., Pulkrabek D. J. Bcl-2 prevents Bax oligomerization in the mitochondrial outer membrane // J Biol Chem. -2001. Vol.276, № 21. — P.18 361−18 374.
- Mojica W.D., Saxena R., Starostik P. CD117+ small cell lung cancer lacks the point mutation in exon 17 // Histopathology. 2005. — Vol. 47, № 5. -P.517−22.
- Moldvay J., Scheid P., Wild P. et al. Predictive survival markers in patients with surgically resected non-small cell lung carcinoma // Clin Cancer Res. 2000. — Vol. 6, № 3. — P. 1125−34.
- Moller A.C., Hellmen E. SI00 protein is not specific for myoepithelial cells in the canine mammary gland. // J Comp Pathol. 1994. — Vol.110, № 1. — P. 49−55.
- Montero J.C., Lopez-Perez R., San Miguel J.F. et al. Expression of c-Kit isoforms in multiple myeloma: differences in signaling and drug sensitivity // Haematologica. 2008. — Vol.93, № 6. — P.851−9.
- Montoro Zulueta F.J., Martinez Prieto M., Verdugo Cartas M. I. et al. Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia With Multiple Synchronous Carcinoid Tumors // Arch Bronconeumol. 2012.-. P. 129−133.
- Moran C.A., Suster S. Neuroendocrine carcinomas (carcinoid, atypical carcinoid, small cell carcinoma, and large cell neuroendocrine carcinoma): current concepts. // Hematol Oncol Clin North Am. 2007. — Vol.21, № 3. -P. 395−407.
- Mueller H. Sur Entstehungsgeschichte der Bronhialerweiterungen. -Busch: Ersleben. 118p.
- Myong N.H. Thyroid transcription factor-1 (TTF-1) expression in human lung carcinomas: its prognostic implication and relationship with expressions of p53 and Ki-67 proteins // J Korean Med Sci. 2003. — Vol. 18, № 4. — P.494−500.
- Nadav L., Katz B.Z. The molecular effects of oncogenesis on cell-extracellular matrix adhesion (review) // Int J Oncol. 2001. — Vol. 19, № 2. -P.237−46.
- Nannini N., Bertolini F., Cavazza A. et al. Atypical carcinoid with prominent mucinous stroma: a hitherto unreported variant of pulmonary neuroendocrine tumor//Endocr Pathol. -2010. Vol. 21, № 2. -P.120−4.
- Nassar A., Amin M., Sexton D. et al. Utility of alpha-methylacyl coenzyme A racemase (p504s antibody) as a diagnostic immunohistochemical marker for cancer. Appl Immunohistochem // Mol Morphol. 2005. — Vol.3, № 3. — P.252−5.
- Nava V.E., Jaffe E.S. The pathology of NK-cell lymphomas and leukemias //Adv Anat Pathol. -2005. Vol. 12. № 1. -P.27−34.
- Neyman K., Sundset A., Naalsund A. et al. Endoscopic treatment of bronchial carcinoids in comparison to surgical resection: a retrospective study. // J Bronchology Interv Pulmonol. 2012. — Vol.19, № 1. — P.29−34.
- Nguyen V.N., Mirejovsky P., Mirejovsky T. et al. Expression of cyclin Dl, Ki-67 and PCNA in non-small cell lung cancer: prognostic significance and comparison with p53 and bcl-2 // Acta Histochem. 2000. — Vol. 102, № 3. -P.323−38.
- Nomura M., Fukuda T., Fujii K. J Preferential expression of potential markers for cancer stem cells in large cell neuroendocrine carcinoma of the lung. An FFPE proteomic study // Clin Bioinforma. 2011. — Vol. 8, № 4. -P.139−46.
- Noske A., Zimmermann A.K., Caduff R. et al. Alpha-methylacyl-CoA racemase (AMACR) expression in epithelial ovarian cancer // Virchows Arch. 2011. — Vol.459, № 1. — P.91 -7.
- Novkovic D., Skuletic V., Vukovic J. et al. Disseminated typical bronchial carcinoid tumor. // Vojnosanit Pregl. 2013. — Vol.70, № 5. -P.516−21.
- Oberndorfer S. Karzinoide Tumoren des Dunndarms // Frankf. Z. Pathol. 1907. -№ l.-P. 425−429.
- Oka S., Uramoto H., Shimokawa H. et al. The expression of Ki-67, but not proliferating cell nuclear antigen, predicts poor disease free survival in patients with adenocarcinoma of the lung // Anticancer Res. 2011. -Vol.31, № 12.-P.277−82.
- Oliveira A.M., Tazelaar H.D., Myers J.L. et al. Thyroid transcription factor-1 distinguishes metastatic pulmonary from well-differentiated neuroendocrine tumors of other sites // Am J Surg Pathol. 2001. — Vol. 25, № 6. -P.815−9.
- Omran O. M., Ata H.S. CD44s and CD44v6 in diagnosis and prognosis of human bladder cancer // Ultrastruct Pathol. 2012. — Vol.36. № 3. -P.:145−52.
- Ouyang B., Leung Y.K., Wang V. et al. a-Methylacyl-CoA racemase spliced variants and their expression in normal and malignant prostate tissues // Urology. 2011. — Vol.77, № 1. — P.249.
- Paik K.H., Park Y.H., Ryoo B.Y. et al. Prognostic value of immunohistochemical staining of p53, bcl-2, and Ki-67 in small cell lung cancer // J Korean Med Sci. 2006. — Vol.21, № 1. — P.35−9.
- Papotti M., Sapino A., Righi L. et al. 34betaE12 cytokeratin immunodetection in the differential diagnosis of neuroendocrine carcinomas of the breast // Appl Immunohistochem Mol Morphol. 2001. — Vol.9, № 3. -P.229−33.
- Paulson Q.X., McArthur M.J., Johnson D.G. et al. E2F3a stimulates proliferation, p53-independent apoptosis and carcinogenesis in a transgenic mouse model // Cell Cycle. 2006. — Vol. 5. № 2. — P. 184−90.
- Pelosi G., Rodriguez J., Viale G. et al. Typical and atypical pulmonary carcinoid tumor overdiagnosed as small-cell carcinoma on biopsy specimens: a major pitfall in the management of lung cancer patients // Am J Surg Pathol. 2005. -№ 29. — P. 179−87.
- Petrovic M., Tomic I., Plavec G. et al. Neuron specific enolase tissue expression as a prognostic factor in advanced non small cell lung cancer. // J BUON.-2008.-Vol. 13, № 1. -P.93−6.
- Petzmann S., Ulimann R., Kiemen H. et al. Loss of heterozygosity on chromosome arm llq in lung carcinoids // Hum Pathol. 2001. — № 32. -P.333−338.
- Ponticiello A., Barra E., Giani U. et al. P53 immunohistochemistry can identify bronchial dysplastic lesions proceeding to lung cancer: a prospective study // Eur Respir J. 2000. — Vol. 15, № 3. — P.547−52.
- Prag S., Lepekhin E. A., Kolkova K. et al. NCAM regulates cell motility // J Cell Sei. 2002. — № 115. — P.283−92.
- Przygodzki R. M., Finkelstein S. D., Langer J. C et al. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome // Am J Pathol. 1996. — № 148. -P.1531−1541.
- Rekhtman N. Neuroendocrine tumors of the lung: an update. // Arch Pathol Lab Med. 2010. — Vol. 134, № 11. — P. 1628−38.
- Remes S.M., Tuominen V.J., Helin H. et al. Grading of Neuroendocrine Tumors With Ki-67 Requires High-quality Assessment Practices // Am J Surg Pathol. 2012. — Vol.36, № 9. — P. 1359−63.
- Reubi J.C., Wenger S., Schmuckli-Maurer J. et al. Bombesin receptor subtypes in human cancers: detection with the universal radioligand (// Clin Cancer Res. 2002. — Vol. 8, № 4. — P. l 139−46.
- Rindi G., Kloppel G., Couvelard A. et al. TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system // Virchows Arch. 2007. -№ 451. — P.757−762.
- Rizvi S.M., Goodwill J., Lim E. et al. The frequency of neuroendocrine cell hyperplasia in patients with pulmonary neuroendocrine tumours and non-neuroendocrine cell carcinomas // Histopathology. 2009. — Vol. 55, № 3. -P.332−7.
- Rodney T., Miller M. D Cytokeratin AE1/AE3 // ProPath. 2003. -№ 37.-P. 1−2.
- Rodney T., Miller M.D. Differential Diagnosis of Cytokeratin Dots // ProPath. 2004.- № 28. — P. 1−2.
- Rudolph P., Aim P., Olsson H. et al. Concurrent overexpression of p53 and c-erbB-2 correlates with accelerated cycling and concomitant poor prognosis in node-negative breast cancer // Human Pathol 2001. -№ 32. -P.311−319.
- Rugge M., Fassan M., Clemente R. et al. Bronchopulmonary carcinoid: phenotype and long-term outcome in a single-institution series of Italian patients // Clin Cancer Res. 2008. — Vol.14, № 1. — P. 149−54.
- Sabah M. s Leader M., Kay E. et al. The problem with KIT: clinical implications and practical difficulties with CD117 immunostaining // Appl Immunohistochem Mol Morphol. -2003. Vol.11, № 1. -P.56−61.
- Saikumar P., Dong Z., Mikhailov V. et al. Apoptosis: defi nition, mechanisms, and relevance to disease // Am J Med. 1999. — Vol.107, № 5. — P.489−506.
- Salon C., Moro D., Lantuejoul S. et al. E-cadherin-beta-catenin adhesion complex in neuroendocrine tumors of the lung: a suggested role upon local invasion and metastasis // Hum Pathol. 2004. — Vol.35, № 9. — P. 1148−55.
- Sands T.J., Soomro I.N., Chaudry Z.R. et al. Prognosis in lung carcinoid tumours. Is there a difference between atypical and typical carcinoids with and without metastasis? // Histopathology. 2006. — Vol.49, № 6. — P.653−4.
- Schaik F.D., Oldenburg B., Offerhaus G.J. et al. Role of immunohistochemical markers in predicting progression of dysplasia to advanced neoplasia in patients with ulcerative colitis // Inflamm Bowel Dis. 2012. — Vol. 18, № 3. — P.480−8.
- Schmitz W., Fingerhut R., Conzelmann E. et al. Purification and properties of an alpha-methylacyl-CoA racemase from rat liver // Eur J Biochem. 1994. — № 222. — P.313−323.
- Sen F., Rassidakis G., Jones D. et al. Apoptosis and Proliferation in Subcutaneous Panniculitis-Like T-Cell Lymphoma // Modern Pathology. -2002. -№ 15. -P.625−631.
- Shabnam M.S., Srinivasan R., Wali A. et al. Expression of p53 protein and the apoptotic regulatory molecules Bcl-2, Bcl-XL, and Bax in locally advanced squamous cell carcinoma of the lung // Lung Cancer. 2004. -Vol. 45, № 2. — P.181−8.
- Sharma S., Mahajan R., Negi A. et al. Atypical Peripheral Bronchial Carcinoid // Ind J Radiol Imag. 2006. — Vol.16, № 2. — P211−214.
- Shen C.H., Wu J.D., Jou Y.C. et al. The correlation between TWIST, E-cadherin, and beta-catenin in human bladder cancer // J BUON. 2011. -Vol. 16,№ 4.-P. 733−7.
- Shibahara J., Goto A., Niki T. et al. Primary pulmonary paraganglioma: report of a functioning case with immunohistochemical and ultrastructural study // Am J Surg Pathol. 2004. — Vol.28, № 6. — P.825−9.
- Shilo K., Dracheva T., Mani H. et al. Alpha-methylacyl CoA racemase in pulmonary adenocarcinoma, squamous cell carcinoma, and neuroendocrine tumors: expression and survival analysis // Arch Pathol Lab Med. 2007. — Vol. 131. № 10. — P. 1555−60.
- Shivapurkar N., Toyooka S., Eby M T. et al. Differential inactivation of caspase-8 in lung cancers // Cancer Biol Ther. 2002. — № 1. — P.65−69.
- Siddiqui M. T. Pulmonary neuroendocrine neoplasms: a review of clinicopathologic and cytologic features. // Diagn Cytopathol. 2010. -Vol.38, № 8.-P. 607−17.
- Situ D., Wang J., Ma Y. et al. Expression and prognostic relevance of MUC1 in stage IB non-small celllung cancer // Med Oncol. 2011. — № 1. -P.596−604.
- Skov B. G., Holm B., Erreboe A. et al. ERCC1 and Ki67 in small cell lung carcinoma and other neuroendocrine tumors of the lung: distribution and impact on survival // J Thorac Oncol. 2010. — Vol.5, № 4. — P.453−9.
- Sobrinho-Simoes M., Oliveira C. Different types of epithelial cadherin alterations play different roles in human carcinogenesis // Adv Anat Pathol. 2002. -.№ 9. — P.329−37.
- Sousa V., Espirito Santo J., Silva M. et al. EGFR/erB-1, HER2/erB-2, CK7, LP34, Ki67 and P53 expression in preneoplastic lesions of bronchial epithelium: an immunohistochemical and genetic study // Virchows Arch. -2011. Vol. 458. № 5. -P.571−81.
- Spindel E. R., Sunday M. E., Hoflfler H. et al. Transient elevation of messenger RNA encoding gastrin releasing peptide, a putative pulmonary growth factor in human fetal lung // J Clin Invest. 1987. — № 80. — P. l 1 721 179.
- Srivastava A., Padilla O. Neuroendocrine secretory protein-55 (NESP-55) expression discriminates pancreatic endocrine tumors and pheochromocytomas from gastrointestinal and pulmonary carcinoids // Am J Surg Pathol. 2004. — Vol.28, № 10. — P. 1371−8.
- Stahlman M. T., Kasselberg A. G., Orth D. N. et al. Ontogeny of neuroendocrine cells in human fetal lung. II. An immunohistochemical study // Lab Invest. 1985. — № 52. — P.52−60.
- Stanculescu D., Margaritescu C., Stepan A. et al. E-cadherin in gastric carcinomas related to histological prognostic parameters // Rom J Moiphol Embryol. 2011. — № 52. — P. 1107−12.
- Stanic J., Zaric B., Anjelkovic A. et al. Clinical prognostic factors and outcome of surgical treatment in patients with early-stage bronchial carcinoid tumors // J BUON. 2010. — Vol.15, № 3. — P.524−8.
- Stenhouse G ., Fyfe N. Thyroid transcription factor 1 in pulmonary adenocarcinoma // J Clin Pathol. 2004. — Vol.57№ 4. — P. 383−7.
- Strappazzon F., Campello S., Cecconi F. et al. Non-apoptotic roles for death-related molecules: When mitochondria chose cell fate // Exp Cell Res. 2012. — Vol.318.№ 11. — P. 1309−15.
- Sturm N., Rossi G., Lantuejoul S. et al. Expression of thyroid transcription factor-1 in the spectrum of neuroendocrine cell lung proliferations with special interest in carcinoids // Hum Pathol. 2002. -Vol.33, № 2.-P.175−82.
- Sun X., Gong Y., Talamonti M. S. et al. Expression of cell adhesion molecules, CD44s and E-cadherin, and microvessel density in carcinoid tumors // Mod Pathol. 2002. — Vol. 15, № 12. — P.1333−8.
- Swarts D. R., Claessen S. M.5 Jonkers Y. M. et al. Deletions of 1 lq22.3-q25 are associated with atypical lung carcinoids and poor clinical outcome. // Am J Pathol. 2011. — Vol.179, № 3. — P. 1129−37.
- Swarts D.R., Ramaekers F. C., Speel E. J. et al. Molecular and cellular biology of neuroendocrine lung tumors: evidence for separate biological entities. //Biochim Biophys Acta. 2012. — Vol.1826, № 2. — P. 255−71.
- Tamasi L., Miiller V. Symptoms and diagnostics of lung neuroendocrine tumors // Orv Hetil. 2011. — Vol. 152, № 10. — P.366−70.
- Thomas C.F., Tazelaar H. D., Jett J. R. et al. Typical and atypical pulmonary carcinoids: outcome in patients presenting with regional lymph node involvement. // Chest. 2001. — № 119. — P. 1143−50.
- Thomas R., Christopher D. J., Balamugesh T. et al. Clinico-pathologic study of pulmonary carcinoid tumours—a retrospective analysis and review of literature//Respir Med.-2008.-Vol. 102, № 11.-P.1611−4.
- Torer N., Kayaselcuk F., Nursal T. Z. et al. Adhesion molecules as prognostic markers in pancreatic adenocarcinoma // J Surg Oncol 2007. -№ 96. — P.419−423.
- Toyooka S., Maruyama R., Toyooka K. O. et al. Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer // Int J Cancer. 2003. — № 103. -P.153−160.
- Tsubochi H., Endo S., Oda Y. et al. Carcinoid tumor of the lung with massive ossification: report of a case showing the evidence of osteomimicry and review of the literature. // Int J Clin Exp Pathol. 2013. — Vol.15, № 6. -P.957−61.
- Travis W.D. Update on small cell carcinoma and its differentiation from squamous cell carcinoma and other non-small cell carcinomas // Mod Pathol.-2012. Vol.25, № 1. -P.18−30.
- Travis W.D., Brambilla E., Muller Hermelink H.K. et al. Pathology and genetics of tumours of the lung, pleura, thymus and heart. Lyon: IARC Press, 2004. — 264 p.
- Trzpis M., McLaughlin P. M., de Leij L. M. et al. Epithelial cell adhesion molecule: more than a carcinoma marker and adhesion molecule. // Am J Pathol. 2007. — Vol.171, № 2. -P.386−95.
- Truong C.D., Li W., Feng W. et al. Alpha-methylacyl-CoA racemase expression is upregulated in gastric adenocarcinoma: a study of 249 cases // Int J C-lin Exp Pathol. 2008. — Vol.1, № 6. — P.518−23.
- Tsuta K., Kalhor N., Raso M.G. et al. Oncocytic neuroendocrine tumors of the lung: histopathologic spectrum and immunohistochemical analysis of 15 cases // Hum Pathol. 2011. — Vol. 42, № 4. — P. 578−85.
- Tsuta K., Raso M.G., Kalhor N. et al. Histologic features of low- and intermediate-grade neuroendocrine carcinoma (typical and atypical carcinoid tumors) of the lung // Lung Cancer. 2011. — Vol. 71. № 1. -P.34−41.
- Vahakangas K.H., Bennett W. P., Castren K. et al. p53 and K-ras mutations in lung cancers from former and never-smoking women // Cancer Res. 2001. — Vol. 61, № 11.-. P.4350−6.
- Valdevenito J.P., Miranda R., Gallegos I. et al. Immunohistochemistry expression of P53, Ki67, CD30, and CD117 and presence of clinicalmetastasis at diagnosis of testicularseminoma // Appl Immunohistochem Mol Morphol- 2011. Vol.19, № 2. — P. 147−52.
- Veschi S., Lattanzio R., Aceto G. et al. Alterations of MEN1 and E-cadherin/p-catenin complex in sporadic pulmonary carcinoids. // Int J Oncol. 2012. — № 20. — P. 63−65.
- Voortman J., Lee J. H., Killian J. K. et al. Array comparative genomic hybridization-based characterization of genetic alterations in pulmonary neuroendocrine tumors. // Proc Natl Acad Sci U S A. 2010. — Vol.107, № 29.-P. 13 040−5.
- Wakamatsu Y., Anami K- Naito Y. et al. Expression of cancer stem cell markers ALDH1, CD44 and CD 133 in primary tumor and lymph node metastasis of gastric cancer // Pathol Int. 2012. — Vol. 62, № 2. — P. l 12−9.
- Wang G.F., Lai M. D., Yang R. R. et al. Histological types and significance of bronchial epithelial dysplasia // Mod Pathol. 2006. — Vol 19, № 3. -P.429−37.
- Wang S.A., Wang L., Hochberg E.P. et al. Low histologic grade follicular lymphoma with high proliferation index: morphologic and clinical features // Am J Surg Pathol. 2005. — Vol. 29, № 11. — P. 1490−6.
- Wang Y.C., Iezza G., Zuraek M. B. et al. Lack of NKX2.2 expression in bronchopulmonary typical carcinoid tumors: implications for patients with neuroendocrine tumor metastases and unknown primary site // J Surg Res. -2010.-Vol.163, 1.-P47−51.
- Warth A., Herpel E, Krysa S. et al. Chromosomal instability is more frequent in metastasized than in non-metastasized pulmonary carcinoids but is not a reliable predictor of metastatic potential. // Exp Mol Med. 2009. -Vol.4, № 5.-P. 349−53.
- Warth A., Krysa S., Zahel T. et al. SI00 protein positive sustentacular cells in pulmonary carcinoids and thoracic paragangliomas: differentialdiagnostic and prognostic evaluation // Pathologe. 2010. — Vol. 31,№ 5. -P379−84.
- Watanabe O., Kinoshita J., Shimizu T. et al. Expression of a CD44 variant and VEGF-C and the implications for lymphatic metastasis and long-term prognosis of human breast cancer // J Exp Clin Cancer Res.2005. Vol. 24. № 1. — P75−82.
- Welin S., Fjallskog M. L., Saras J. et al. Expression of tyrosine kinase receptors in malignant midgutcarcinoid tumors // Neuroendocrinology.2006. Vol.84, № 1. -P.42−8.
- Wiedenmann B., Franke W.W., Kuhn C. et al. Synaptophysin: a marker protein for neuroendocrine cells and neoplasms // Proc Natl Acad Sei U S A. 1986. — Vol. 83, № 10. -P.3500−4.
- Wilson B.A., Wang H., Nacev B. et al. High-throughput screen identifies novel inhibitors of cancer biomarker a-methylacyl coenzyme A racemase (AMACR/P504S) // Mol Cancer 2011. — Vol. 10, № 5. — P.825−38.
- Wimmel A., Kogan E., Ramaswamy A. et al. Variant expression of CD44 in preneoplastic lesions of the lung // Cancer. 2001. Vol. 92, № 5. -P. 1231−6.
- Windoffer R., Beil M., Magin T. M. et al. Cytoskeleton in motion: the dynamics of keratin intermediate filaments in epithelia // J Cell Biol. 201. -Vol. 194, № 5. — P.669−78.
- Windoffer R., Wtill S., Straad P. et al. Identification on novel principles of keratin filament network turnover living cells // MBC. 2004. — Vol 15, № 5.-P. 2436 2448.
- Wohlschlager J., Wittekind C., Theegarten D. et al. New TNM classification of malignant lung tumours // Pathologe. 2010. — Vol 31, № 5. -P.355−60.
- Wu K., Zeng J., Zhou J. Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development // Urol Oncol.-2012.
- Wurtz A. J. Hysi I., Benhamed L. et al. Surgical management of carcinoid tumours of the lung: sublobar resection versus lobectomy. // Interact Cardiovasc Thorac Surg. 2013. -№ 6. — P. 176−182.
- Yamada H., Otsuka M, Hayashi M. et al. Ca2±dependent exocytosis of L-glutamate by alphaTC6, clonal mouse pancreatic alpha-cells // Diabetes. — 2001. Vol 50, № 5. -P.1012−20.
- Yang G.Z., Zhang X.L., Li J. et al. Expression of E-cadherin, pl20catenin and 34{3E12 in invasive lobular carcinoma of breast and their roles in diagnosis // Zhonghua Bing Li Xue Za Zhi. 2011. — Vol. 40, № 11. -P.741−4.
- Yao J.C., Hassan M., Phan A. et al. One hundred years after «carcinoid»: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. // J Clin Oncol. 2008. — Vol.26, № 18. -P.3063−72.
- Yasuda M., Nakano K., Yasumoto K. et al. CD44: functional relevance to infl ammation and malignancy // Histol Histopathol. 2002. — № 17. -P.945−950.
- Yeudall W.A., Vaughan C.A., Miyazaki H. et al. Gain-of-fiinction mutant p53 upregulates CXC chemokines and enhances cell migration // Carcinogenesis. -2012. Vol.33, № 2. -P.442−51.
- Yoo S.H., Jung K.C., Kim J.H. et al. Expression patterns of markers for type II pneumocytes in pulmonary sclerosing hemangiomas and fetal lung tissues // Arch Pathol Lab Med. 2005. — Vol.129, № 7. — P.915−9.
- Yun J.P., Xiang J., Hou J.H. et al. Expression ofCD56, as a potential diagnostic marker, in small cellcarcinoma // 2005. Vol 24, № 9. — P. l 1403.
- Zaffaroni N., De Polo D., Villa R. et al. Differential expression of telomerase activity in neuroendocrine lung tumours: correlation with gene product immunophenotyping // J Pathol. 2003. — Vol 201, № 1. — P. 12 733.
- Zahel T., Krysa S., Herpel E et al. Phenotyping of pulmonary carcinoids and a Ki-67-based grading approach // Virchows Arch. 2012 — Vol 460, № 3. — P. 299−308.
- Zhang M.H., Liu Y.H., Luo X.L. et al. Neuroendocrine neoplasm of digestive system with different grades: a clinicopathologic and prognostic study // Zhonghua Bing Li Xue Za Zhi. 2012. — Vol.41, № 7. — P.448−51.
- Zhong C.X., Yao F., Zhao H. et al. Long-term outcomes of surgical treatment for pulmonary carcinoid tumors: 20 years' experience with 131 patients. // Chin Med J. 2012. — Vol.215, № 17. — P. 3022−6.